U.S. Markets close in 50 mins
  • S&P 500

    3,838.45
    -3.49 (-0.09%)
     
  • Dow 30

    31,914.28
    +417.98 (+1.33%)
     
  • Nasdaq

    12,660.47
    -259.68 (-2.01%)
     
  • Russell 2000

    2,209.67
    +17.46 (+0.80%)
     
  • Crude Oil

    64.81
    -1.28 (-1.94%)
     
  • Gold

    1,681.20
    -17.30 (-1.02%)
     
  • Silver

    25.24
    -0.05 (-0.19%)
     
  • EUR/USD

    1.1857
    -0.0068 (-0.5691%)
     
  • 10-Yr Bond

    1.5940
    +0.0400 (+2.57%)
     
  • Vix

    25.32
    +0.66 (+2.68%)
     
  • GBP/USD

    1.3829
    +0.0001 (+0.0041%)
     
  • USD/JPY

    108.8650
    +0.4830 (+0.4456%)
     
  • BTC-USD

    50,947.24
    +92.13 (+0.18%)
     
  • CMC Crypto 200

    1,039.93
    +15.72 (+1.54%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Quest Diagnostics (DGX) Ties Up With Hackensack Meridian Health

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Quest Diagnostics DGX recently inked a deal to partner with New Jersey- based integrated healthcare network, Hackensack Meridian Health “HMH.” This collaboration is aimed to enhance the quality and value of diagnostic services offered to patients and doctors.

Per the global diagnostic information service provider, Quest Diagnostics will manage laboratory operations and perform reference testing for 11 Hackensack Meridian Health hospitals under the long-term full laboratory management agreement.

Notably, the financial and other terms of the agreement have not been disclosed yet.

More on Hackensack Meridian Health

Hackensack Meridian Health offers a full spectrum of life-enhancing care and services to create and sustain healthy and vibrant communities. The company has a wide range of network throughout the state which includes ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, urgent care centers and physician practice locations.

Significance of the Collaboration

With this collaboration, Quest Diagnostics intends to deliver high quality, convenient and accessible health care to meet communities expectations. This partnership will help boost the COVID-19 testing capacity for the health care network through quicker turnaround time for the acquisition of testing materials and diagnostic results.

The collaboration between Quest Diagnostics and Hackensack Meridian Health will enable high-quality health care services and open up new opportunities to improve patient outcomes.

This partnership is in line with the company’s existing strategy to focus on collaborating with complementary business that helps the company broaden its scope of delivering high quality laboratory experience to clients. This partnership is likely to strengthen Quest Diagnostics' portfolio.

Recent Notable Developments

In November 2020, Quest Diagnostics partnered with two hospitals Montefiore Nyack Hospital and its renal physician practice Highland Medical Rockland health system to enhance the quality and value of diagnostic services. Additionally, the company entered into a professional laboratory services relationship with Goshen Hospital in Indiana, to provide supply chain management expertise.

In September 2020, Quest Diagnostics launched QuestDirect through which individuals can now purchase COVID-19 test online. This is a highly sensitive molecular diagnostic technology that has received emergency authorization from the FDA for the detection of the RNA of SARS-COV-2.

Industry Prospects

Per a report by Grand View Research, the global clinical laboratory services market size is expected to reach $326.97 billion by 2025 at a CAGR of 6.4%. Rise in chronic diseases and surge in demand for accurate disease diagnosis are primarily driving the market.

Price Performance

Shares of Quest Diagnostics have gained 13.1% in the past year compared with the industry’s growth of 21.4%.

Zacks Rank and Other Key Picks

Quest Diagnostics currently carries a Zacks Rank #2 (Buy).

A few similar-ranked stocks from the broader medical space include Addus Homecare Corporation ADUS, Chemed Corporation CHE, DaVita Inc. DVA, each carrying a Zacks Rank #2. You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here.

Addus Homecare has a projected long-term growth rate of 15%.

Chemed has a projected long-term growth rate of 10.10%.

DaVita has a projected long-term growth rate of 18.30%.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Quest Diagnostics Incorporated (DGX) : Free Stock Analysis Report
 
DaVita Inc. (DVA) : Free Stock Analysis Report
 
Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report
 
Chemed Corporation (CHE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research